| 000 | 01398 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517163716.0 | ||
| 264 | 0 | _c20170904 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1751-2441 | ||
| 024 | 7 |
_a10.1080/17512433.2017.1356717 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSantini, Fernando C | |
| 245 | 0 | 0 |
_aAtezolizumab for the treatment of non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bExpert review of clinical pharmacology _cSep 2017 |
||
| 300 |
_a935-945 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aB7-H1 Antigen _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 700 | 1 | _aRudin, Charles M | |
| 773 | 0 |
_tExpert review of clinical pharmacology _gvol. 10 _gno. 9 _gp. 935-945 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/17512433.2017.1356717 _zAvailable from publisher's website |
| 999 |
_c27374620 _d27374620 |
||